- Home
- CZR vs ROIV Comparison
CZR vs ROIV Comparison
Compare CZR & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZR
- ROIV
- Stock Information
- Founded
- CZR 1937
- ROIV 2014
- Country
- CZR United States
- ROIV United Kingdom
- Employees
- CZR N/A
- ROIV N/A
- Industry
- CZR Hotels/Resorts
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- CZR Consumer Discretionary
- ROIV Health Care
- Exchange
- CZR Nasdaq
- ROIV Nasdaq
- Market Cap
- CZR 8.7B
- ROIV 8.4B
- IPO Year
- CZR 1989
- ROIV N/A
- Fundamental
- Price
- CZR $33.19
- ROIV $10.94
- Analyst Decision
- CZR Strong Buy
- ROIV Strong Buy
- Analyst Count
- CZR 13
- ROIV 8
- Target Price
- CZR $50.77
- ROIV $17.93
- AVG Volume (30 Days)
- CZR 4.6M
- ROIV 5.3M
- Earning Date
- CZR 02-25-2025
- ROIV 02-11-2025
- Dividend Yield
- CZR N/A
- ROIV N/A
- EPS Growth
- CZR N/A
- ROIV N/A
- EPS
- CZR N/A
- ROIV 5.89
- Revenue
- CZR $11,271,000,000.00
- ROIV $129,128,999.00
- Revenue This Year
- CZR N/A
- ROIV $15.98
- Revenue Next Year
- CZR $3.49
- ROIV N/A
- P/E Ratio
- CZR N/A
- ROIV $1.86
- Revenue Growth
- CZR N/A
- ROIV 145.68
- 52 Week Low
- CZR $30.78
- ROIV $9.69
- 52 Week High
- CZR $47.99
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- CZR 43.11
- ROIV 38.75
- Support Level
- CZR $30.78
- ROIV $10.42
- Resistance Level
- CZR $34.33
- ROIV $11.82
- Average True Range (ATR)
- CZR 1.16
- ROIV 0.35
- MACD
- CZR 0.13
- ROIV -0.11
- Stochastic Oscillator
- CZR 67.85
- ROIV 29.21
About CZR Caesars Entertainment Inc.
Caesars Entertainment includes about 50 domestic gaming properties across Las Vegas (49% of 2023 EBITDAR before corporate expenses) and regional (48%) markets. Additionally, the company hosts managed properties and digital assets, the later of which produced marginal EBITDA in 2023. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.